95 related articles for article (PubMed ID: 22177779)
1. Selective endoscopic treatment of the non-refluxing contralateral ureter prevents new contralateral vesicoureteral reflux.
Cerwinka WH; Kaye JD; Leong TL; Elmore JM; Scherz HC; Kirsch AJ
J Pediatr Urol; 2013 Feb; 9(1):51-5. PubMed ID: 22177779
[TBL] [Abstract][Full Text] [Related]
2. Unilateral vesicoureteral reflux: does endoscopic injection based on the cystoscopic appearance of the ureteral orifice decrease the incidence of de-novo contralateral reflux?
Routh JC; Inman BA; Ashley RA; Vandersteen DR; Reinberg Y; Wolpert JJ; Kramer SA; Husmann DA
J Pediatr Urol; 2008 Aug; 4(4):260-4. PubMed ID: 18644526
[TBL] [Abstract][Full Text] [Related]
3. New contralateral vesicoureteral reflux following dextranomer/hyaluronic Acid implantation: incidence and identification of a high risk group.
Elmore JM; Kirsch AJ; Lyles RH; Perez-Brayfield MR; Scherz HC
J Urol; 2006 Mar; 175(3 Pt 1):1097-100; discussion 1100-1. PubMed ID: 16469630
[TBL] [Abstract][Full Text] [Related]
4. Commentary to 'Selective endoscopic treatment of the non-refluxing contralateral ureter prevents new contralateral vesicoureteral reflux'.
Routh JC
J Pediatr Urol; 2013 Feb; 9(1):55-6; discussion 56. PubMed ID: 22264625
[No Abstract] [Full Text] [Related]
5. Unilateral vesicoureteral reflux and history of contralateral vesicoureteral reflux warranting routine bilateral endoscopic correction.
Chertin B; Natsheh A; Fadeev D; Shenfeld OZ; Farkas A
J Urol; 2008 Oct; 180(4 Suppl):1601-3; discussion 1604. PubMed ID: 18710733
[TBL] [Abstract][Full Text] [Related]
6. Dynamic hydrodistention classification of the ureter and the double hit method to correct vesicoureteral reflux.
Cerwinka WH; Scherz HC; Kirsch AJ
Arch Esp Urol; 2008 Oct; 61(8):882-7. PubMed ID: 19040157
[TBL] [Abstract][Full Text] [Related]
7. Minimally invasive treatment of vesicoureteral reflux with endoscopic injection of dextranomer/hyaluronic acid copolymer: the Children's Hospitals of Atlanta experience.
Kirsch AJ; Perez-Brayfield MR; Scherz HC
J Urol; 2003 Jul; 170(1):211-5. PubMed ID: 12796692
[TBL] [Abstract][Full Text] [Related]
8. Endoscopic injection of dextranomer hyaluronic acid copolymer for the treatment of vesicoureteral reflux in duplex ureters.
Molitierno JA; Scherz HC; Kirsch AJ
J Pediatr Urol; 2008 Oct; 4(5):372-6. PubMed ID: 18790423
[TBL] [Abstract][Full Text] [Related]
9. Treatment of vesicoureteral reflux using endoscopic injection of nonanimal stabilized hyaluronic acid/dextranomer gel: initial experience in pediatric patients by a single surgeon.
Yu RN; Roth DR
Pediatrics; 2006 Aug; 118(2):698-703. PubMed ID: 16882825
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of hydrodistention of the ureteral orifice.
Moralıoğlu S; Celayir AC; Bosnali O
J Pediatr Urol; 2015 Dec; 11(6):354.e1-4. PubMed ID: 26210696
[TBL] [Abstract][Full Text] [Related]
11. [Endoscopic injection of dextranomer/hyaluronic acid for vesico-ureteral reflux--preliminary results].
Bar-Yosef Y; Binyamini J; Sofer M; Matzkin H; Ben-Chaim J
Harefuah; 2005 Sep; 144(9):613-5, 679, 678. PubMed ID: 16218529
[TBL] [Abstract][Full Text] [Related]
12. Long-term results of endoscopic treatment of vesicoureteral reflux in children: comparison of different bulking agents.
Stredele RJ; Dietz HG; Stehr M
J Pediatr Urol; 2013 Feb; 9(1):71-6. PubMed ID: 22212178
[TBL] [Abstract][Full Text] [Related]
13. Long-term incidence of febrile UTI after DxHA treatment of VUR.
Fotso Kamdem A; Galli G; Aubert D
J Pediatr Urol; 2014 Feb; 10(1):56-61. PubMed ID: 23810062
[TBL] [Abstract][Full Text] [Related]
14. Acute and delayed vesicoureteral obstruction after endoscopic treatment of primary vesicoureteral reflux with dextranomer/hyaluronic acid copolymer: why and how to manage.
García-Aparicio L; Rodo J; Palazon P; Martín O; Blázquez-Gómez E; Manzanares A; García-Smith N; Bejarano M; de Haro I; Ribó JM
J Pediatr Urol; 2013 Aug; 9(4):493-7. PubMed ID: 23507288
[TBL] [Abstract][Full Text] [Related]
15. Endoscopic treatment of moderate and high grade vesicoureteral reflux in infants using dextranomer/hyaluronic acid.
Puri P; Mohanan N; Menezes M; Colhoun E
J Urol; 2007 Oct; 178(4 Pt 2):1714-6; discussion 1717. PubMed ID: 17707016
[TBL] [Abstract][Full Text] [Related]
16. Dextranomer/hyaluronic acid endoscopic injection is effective in the treatment of intermediate and high grade vesicoureteral reflux in patients with complete duplex systems.
Hunziker M; Mohanan N; Puri P
J Urol; 2013 May; 189(5):1876-81. PubMed ID: 23159268
[TBL] [Abstract][Full Text] [Related]
17. Is routine voiding cystourethrogram necessary following double hit for primary vesicoureteral reflux?
Arlen AM; Scherz HC; Filimon E; Leong T; Kirsch AJ
J Pediatr Urol; 2015 Feb; 11(1):40.e1-5. PubMed ID: 25725613
[TBL] [Abstract][Full Text] [Related]
18. Multivariate comparison of the efficacy of intraureteral versus subtrigonal techniques of dextranomer/hyaluronic acid injection.
Routh JC; Reinberg Y; Ashley RA; Inman BA; Wolpert JJ; Vandersteen DR; Husmann DA; Kramer SA
J Urol; 2007 Oct; 178(4 Pt 2):1702-5; discussion 1705-6. PubMed ID: 17707019
[TBL] [Abstract][Full Text] [Related]
19. Endoscopic treatment of vesicoureteral reflux associated with paraureteral diverticula in children.
Cerwinka WH; Scherz HC; Kirsch AJ
J Urol; 2007 Oct; 178(4 Pt 1):1469-73. PubMed ID: 17706704
[TBL] [Abstract][Full Text] [Related]
20. Histology proved malpositioning of dextranomer/hyaluronic acid in submucosal ureter in patients after failed endoscopic treatment of vesicoureteral reflux.
Ben-Meir D; Morgenstern S; Sivan B; Efrat R; Livne PM
J Urol; 2012 Jul; 188(1):258-61. PubMed ID: 22595062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
